PubMed Health⌕ Search

PubMed · 131136

Common plantar hyperkeratoses.

Abstract

In general, metatarsal bars have provided a simple method of relieving pain and disability caused by plantar hyperkeratoses over metatarsal heads. By spanning the longitudinal arch, the bars effectively relieve pressure from the middle three metatarsal heads and elevate the distal portion of the metatarsal bones. This often results in favorable repositioning of displaced proximal phalanges and eliminates direct pressure exerted by metatarsal heads. Also, by giving more uniform support to the foot, metatarsal bars rearrange the weight-bearing surface in a more even way, which favors resolution of hyperkeratoses by removal of pressure points. The prescription for metatarsal bars must be written for both shoes. Dual bars provide balanced walking surfaces and do not induce asymmetric motion of the lower spine as a single bar would. They can be applied to moderately high-heeled shoes for women and regular oxfords for men. The leading edge of the bar must be properly skived and tapered to provide an even surface with the forward part of the soles of the shoes. If this is not done properly, the bars may strike against uneven surfaces as the foot slides forward in walking or running. The patient should return to the prescribing physician in two or three weeks after the bars have been worn constantly. By analyzing the scuffed surfaces of the metatarsal bars, the physician can determine whether or not the bars are firm and thick enough and in the proper position to relieve and divert pressure from the metatarsal heads. Perhaps two pair of shoes should be thus altered to provide a change of foot gear for ordinary purposes. Unaltered dress shoes may be worn for short periods of time as party or formal occasions demand. Eventually, when the painful processes have subsided, the patient may resume wearing ordinary shoes and use the modified shoes if symptoms recur from time to time.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G L Engler, R C Gibbs. 1975. Common plantar hyperkeratoses.. https://doi.org/10.1111/j.1524-4725.1975.tb00099.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management.

The diabetic foot syndrome is a major complication of diabetes mellitus. The two most important pathophysiologic factors are peripheral arterial occlusion and peripheral neuropathy. The cutaneous lesion is a plantar ulcer, often accompanied by soft tissue and bone infections which can require amputation. Triggers include poorly fitting shoes, poor foot care, or overlooked foreign bodies, often coupled with a structural foot deformity. Increased plantar pressure, especially beneath the metatarsal heads, and the resultant callus play an important role. The patients often already have xerosis of the plantar skin with scales, fissures, erosions and impaired barrier function, complicating the situation. Prompt neurologic and vascular diagnostic studies, coupled with routine examination of the feet and primary prophylactic measures are most important. The most important therapeutic goals are optimal control of the diabetes mellitus, relieving pressure points and avoiding or reducing callus formation.

Callosities↗

Injectable silicone and the foot: a 41-year clinical and histologic history.

BACKGROUND: Since 1964, the author has investigated injectable liquid silicone as a soft tissue substitute for the loss of plantar fat. This form of fatty tissue depletion over the sole is closely linked to a common painful weight-bearing foot disorder, metatarsalgia, and to painless diabetic foot ulcers. OBJECTIVES: To present the history of injectable silicone, corporate interest, individuals who helped pursue approval, its misuses, and events that have delayed its availability. MATERIALS AND METHODS: Dow Corning Corporation's 360 Medical Fluid of 350 centistoke was injected beneath corns and calluses in 1585 patients. Diabetic neuropathic foot ulcers were injected after healing in an effort to prevent their recurrence. Surgical and postmortem specimens were gathered for histologic analysis. RESULTS: There was no evidence of significant adverse response in long-term clinical follow-up. Silicone specimens studied by two departments of pathology found no inflammation, infection, allergy, or granulomas. CONCLUSIONS: Medical Fluid silicone appears to be safe, effective, and stable biomaterial for treating weight-bearing loss of plantar fat. Trademarked PodiSil (Richard-James Inc., Peabody, MA, USA), a 350-centistoke injectable silicone has been approved for marketing in Europe for the prevention of diabetic foot ulcers.

Callosities↗